Reversible posterior leukencephalopathy syndrome induced by granulocyte stimulating factor filgrastim.
Leniger
T
T
Kastrup
O
O
Diener
H C
HC
D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D019575:Blindness, Cortical / Q000209:etiology; D003221:Confusion / Q000209:etiology; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D009778:Occipital Lobe / Q000473:pathology; D010296:Parietal Lobe / Q000473:pathology; D011994:Recombinant Proteins; D012074:Remission Induction; D012640:Seizures / Q000209:etiology
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D004232:Diuretics; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim